| Anti-angiogenic and anti-inflammatory effects of long-circulating liposomes co-encapsulating curcumin and doxorubicin on C26 murine colon cancer cells A Sesarman, L Tefas, B Sylvester, E Licarete, V Rauca, L Luput, L Patras, ... Pharmacological reports 70 (2), 331-339, 2018 | 75 | 2018 |
| Co-delivery of curcumin and doxorubicin in PEGylated liposomes favored the antineoplastic C26 murine colon carcinoma microenvironment A Sesarman, L Tefas, B Sylvester, E Licarete, V Rauca, L Luput, L Patras, ... Drug delivery and translational research 9, 260-272, 2019 | 65 | 2019 |
| Trojan horse treatment based on PEG-coated extracellular vesicles to deliver doxorubicin to melanoma in vitro and in vivo L Patras, AE Ionescu, C Munteanu, R Hajdu, A Kosa, A Porfire, E Licarete, ... Cancer Biology & Therapy 23 (1), 1-16, 2022 | 26 | 2022 |
| In vivo double targeting of C26 colon carcinoma cells and microenvironmental protumor processes using liposomal simvastatin L Luput, E Licarete, DM Drotar, AL Nagy, A Sesarman, L Patras, ... Journal of Cancer 9 (2), 440, 2018 | 26 | 2018 |
| Biologically Active Ajuga Species Extracts Modulate Supportive Processes for Cancer Cell Development VF Rauca, L Vlase, T Casian, A Sesarman, AM Gheldiu, A Mocan, ... Frontiers in Pharmacology 10, 334, 2019 | 24 | 2019 |
| Improved pharmacokinetics and reduced side effects of doxorubicin therapy by liposomal co-encapsulation with curcumin A Sesarman, D Muntean, B Abrudan, L Tefas, B Sylvester, E Licarete, ... Journal of Liposome Research 31 (1), 1-10, 2021 | 22 | 2021 |
| Overcoming intrinsic doxorubicin resistance in melanoma by anti-angiogenic and anti-metastatic effects of liposomal prednisolone phosphate on tumor microenvironment E Licarete, VF Rauca, L Luput, D Drotar, I Stejerean, L Patras, B Dume, ... International journal of molecular sciences 21 (8), 2968, 2020 | 21 | 2020 |
| A screening study for the development of simvastatin-doxorubicin liposomes, a co-formulation with future perspectives in colon cancer therapy CI Barbălată, AS Porfire, A Sesarman, VF Rauca, M Banciu, D Muntean, ... Pharmaceutics 13 (10), 1526, 2021 | 20 | 2021 |
| Combination therapy of simvastatin and 5, 6-dimethylxanthenone-4-acetic acid synergistically suppresses the aggressiveness of B16. F10 melanoma cells VF Rauca, E Licarete, L Luput, A Sesarman, L Patras, P Bulzu, ... PLoS One 13 (8), e0202827, 2018 | 20 | 2018 |
| HIF‑1α acts as a molecular target for simvastatin cytotoxicity in B16. F10 melanoma cells cultured under chemically induced hypoxia E Licarete, A Sesarman, VF Rauca, L Luput, L Patras, M Banciu Oncology letters 13 (5), 3942-3950, 2017 | 18 | 2017 |
| Liposomal simvastatin sensitizes C26 murine colon carcinoma to the antitumor effects of liposomal 5‐fluorouracil in vivo L Luput, A Sesarman, A Porfire, M Achim, D Muntean, T Casian, L Patras, ... Cancer science 111 (4), 1344-1356, 2020 | 15 | 2020 |
| Active tumor-targeting nano-formulations containing simvastatin and doxorubicin inhibit melanoma growth and angiogenesis G Negrea, VF Rauca, MS Meszaros, L Patras, L Luput, E Licarete, ... Frontiers in Pharmacology 13, 870347, 2022 | 11 | 2022 |
| Remodeling tumor microenvironment by liposomal codelivery of DMXAA and simvastatin inhibits malignant melanoma progression VF Rauca, L Patras, L Luput, E Licarete, VA Toma, A Porfire, AC Mot, ... Scientific reports 11 (1), 22102, 2021 | 10 | 2021 |
| The prednisolone phosphate‑induced suppression of the angiogenic function of tumor‑associated macrophages enhances the antitumor effects of doxorubicin on B16. F10 murine … E Licarete, VF Rauca, L Luput, L Patras, A Sesarman, M Banciu Oncology Reports 42 (6), 2694-2705, 2019 | 7 | 2019 |
| S, tiufiuc CI Barbălată, AS Porfire, A Sesarman, VF Rauca, M Banciu, D Muntean R, 0 | 5 | |
| Targeting of M2 macrophages with IL-13-functionalized liposomal prednisolone inhibits melanoma angiogenesis in vivo A Sesarman, L Luput, VF Rauca, L Patras, E Licarete, MS Meszaros, ... Journal of Liposome Research, 1-12, 2024 | | 2024 |
| The use of functionalized liposomes and extracellular vesicles as drug delivery systems with high cancer-targeting efficacy. VF Rauca, L Pătraş, G Negrea, E Licărete, A Porfire, L Barbu, L Luput, ... Studia Universitatis Babes-Bolyai, Historia Artium 68 (2), 2023 | | 2023 |
| 3D tumor spheroids as a model to unriddle the complexity of tumor microenvironment chemoresistance. G Negrea, S Meszaros, S Drăgan, VA Toma, B Dume, VF Rauca, L Pătraş, ... Studia Universitatis Babes-Bolyai, Historia Artium 68 (2), 2023 | | 2023 |
| 487 Mast cells alter the invasive properties of melanoma cells in vitro VF Rauca, CI Iuliano, K Mayer, S Kaesler, T Biedermann Journal of Investigative Dermatology 142 (12), S264, 2022 | | 2022 |
| Novel combined therapy based on IL-13-PEG-LCL-SIM and PEG-EV-DOX to reduce murine melanoma aggresiveness in vivo. G Negrea, VF Rauca, L Pătraș, L Luput, E Licărete, VA Toma, B Dume, ... Studia Universitatis Babes-Bolyai, Biologia 66 (1), 2021 | | 2021 |
